G. Guo et al. / Tetrahedron: Asymmetry 27 (2016) 740–746
745
4
ne
.4.1. (S)-2-[(R)-Hydroxy(4-nitrophenyl)methyl] cyclohexano-
(major) and 33.28 min; 1H NMR (300 MHz, CDCl
5H), 1.91–2.21 (m, 1H), 2.26–2.49 (m,3H), 3.01–3.20 (br s, 1H),
3.88–3.92 (br s, 1H), 4.70–4.73 (d, J = 9 Hz, 1H), 5.29 (s, 1H),
6.96–7.00 (m, 2H), 7.20–7.23 (br s, 2H).
3
):1.41–1.87 (m,
5
c,8b
20
D 3
White powder; mp 129–130 °C; [a] = +12.8 (c 1.85, CHCl ).
Enantiomeric excess was determined by HPLC with a Chiralpak
AD-H column (n-hexane/isopropanol, volume ratio 92:8), flow rate
1
2
.0 mL/min, k = 268 nm;
9.86 min, t
(syn) = 22.99 min and 26.25 min (major); 1H NMR
): 8.20–8.24 (m, 2H), 7.48–7.54 (m, 2H), 4.90 (d,
J = 8.1 Hz, 1H), 4.09 (s, 1H), 2.32–2.64 (m, 3H), 2.08–2.16 (m, 1H),
t
R
(anti) = 40.25 min (major) and
.4.7. (S)-2-[(R)-Hydroxy(phenyl)methyl] cyclohexanone14a
Enantiomericexcess was determined by HPLC with a Chiralpak
4
R
(
300 MHz, CDCl
3
AS-H column (n-hexane/isopropanol = 95:5), flow rate 0.5 mL/
min, k = 221 nm; t (anti) = 40.79 min (major) and 43.94 min, t (-
syn) = 29.19 min and 37.08 min (major); NMR (300 MHz,
R
R
1
.82–1.86 (m, 1H), 1.35–1.73 (m, 4H).
1
H
CDCl3): d 1.40–1.22 (m,1H), 1.72–1.50 (m, 3H), 1.87–1.73 (m,
1H), 2.16–2.03 (m, 1H), 2.34 (td, J = 12.3, 5.4 Hz, 1H), 2.55–2.44
(m, 1H), 2.70–2.56 (m,1H), 4.00(m, 1H), 4.80 (d, J = 9.0 Hz, 1H),
7.39–7.28 (m, 5H).
4
ne
.4.2. (S)-2-[(R)-Hydroxy(2,4-nitrophenyl)methyl] cyclohexano-
5
c,8b
Yellow oil. Enantiomeric excess was determined by HPLC with a
Chiralpak AD-H column (n-hexane/isopropanol, volume ratio
9
3
2:8), flow rate 1.0 mL/min, k = 254 nm; t
9.37 min (major), t (syn) = 24.60 min and 32.95 min (major);
): 8.74–8.75 (d, J = 2.3 Hz, 1H), 8.45–8.49
d, J = 8.7 Hz, J = 2.4 Hz, 1H), 8.06–8.08 (d, J = 8.7 Hz, 1H), 6.05–
.06 (d, J = 1.9 Hz, 1H), 5.51–5.53 (br s, 1H), 2.73–2.77 (m, 1H),
.44–2.47 (m, 1H), 2.11–2.33 (m, 1H), 2.04–2.14 (m, 1H), 1.82–
.88 (m, 1H), 1.79–1.82 (m, 1H), 1.69–1.79 (m, 1H), 1.61–1.68
R
(anti) = 44.06 min and
.4.8. (2S,10R)-2-(Hydroxy-(4-tolyl)methyl) cyclohexanone1e
Enantiomericexcess was determined by HPLC with a Chiralpak
4
1
R
H
NMR (400 MHz, CDCl
(
6
2
1
3
AD-H column (n-hexane/isopropanol = 90:10), flow rate 0.5 mL/
min, k = 221 nm; t = 32.8 min (anti, major), t = 44.5 min (anti,
NMR(300 MHz, CDCl3): 7.18 (dd, 4H, J = 17.1,
.4 Hz), 4.75 (dd, 1H, J = 9.0, 2.7 Hz), 3.91 (d, 1H, J = 2.7 Hz), 2.66–
R
R
1
minor).
H
d
8
2
2
3
.54 (m, 1H), 2.51–2.43 (m, 1H), 2.35 (td, 1H, J = 13.2, 6.0 Hz),
.34 (s, 3H), 2.14–2.03(m, 1H), 1.82–1.72 (m, 1H), 1.70–1.50 (m,
H), 1.38–1.18 (m, 1H).
(
m, 1H).
4
ne
.4.3. (S)-2-[(R)-Hydroxy(2-nitrophenyl)methyl] cyclohexano-
5
c,8b
4
ne
.4.9. 2-[Hydroxyl(4-methoxyphenyl)-methyl] cyclohexano-
24
Yellow powder; mp 116–118 °C; [
a]
D
= +19.8 (c 1.60, CHCl
3
).
5c,8b
Enantiomeric excess was determined by HPLC with a Chiralpak
AD-H column (n-hexane/isopropanol, volume ratio 92:8), flow rate
White powder; mp 74–76 °C; [Daicel Chiralpak AD-H column,
n-hexane/isopropanol = 92: 8, flow rate 1.0 mL/min, k = 218 nm;
(anti) = 36.54 min and 29.20 min, t (syn) = 25.25 min (major)
and 21.15 min]; H NMR (300 MHz, CDCl ) d: 1.19–1.33 (m, 1H),
.48–1.81 (m, 4H), 2.05–2.13 (m, 1H), 2.31–2.64 (m, 3H), 3.80 (s,
1
.0 mL/min, k = 209 nm;
t
R
(anti) = 24.05 min and 22.53 min
t
R
R
1
(
(
(
major); H NMR (300 MHz, CDCl ): 7.84 (d, J = 7.8 Hz, 1H), 7.77
d, J = 7.8 Hz, 1H), 7.64 (t, J = 7.2 Hz, 1H), 7.40–7.46 (m, 1H), 5.44
d, J = 7.2 Hz, 1H), 4.11 (br, 1H), 2.73–2.81 (m, 1H), 2.29–2.48 (m,
3
1
3
1
3
7
H), 3.92 (s, 1H), 4.74 (d, J = 8.7 Hz, 1H), 6.86–6.90 (m, 2H), 7.22–
.26 (m, 2H).
2
H), 2.04–2.14 (m, 1H), 1.55–1.86 (m, 5H).
4
ne
.4.4. (S)-2-[(R)-Hydroxy(3-nitrophenyl)methyl] cyclohexano-
5
c,8b
4.4.10. (S)-2-[(R)-hydroxyl(4-nitrophenyl)methyl] cyclopentan-
5
c
24
one
Light yellow powder; mp 88–90 °C; [
CHCl ). Enantiomeric excess was determined by HPLC with a Chi-
ralpak AD-H column (n-hexane/isopropanol = 90:10), 1.0 mL/min,
k = 254 nm; t (anti) = 23.94 min (major) and 23.06 min, t (syn)
13.95 min and 18.04 min (major); H NMR (300 MHz, CDCl ): d
D 3
White powder; mp 69–71 °C; [a] = +32.5 (c 1.35, CHCl ).
2
2
a]
D
= ꢁ30.6 (c 0.56,
Enantiomeric excess was determined by HPLC with a Chiralpak
AD-H column (n-hexane/isopropanol, volume ratio 92:8), flow rate
3
1
.0 mL/min, k = 263 nm;
major), (syn) = 23.10 min (major) and 22.08 min;
300 MHz, CDCl ): 8.15–8.22 (m, 2H), 7.67 (d, J = 7.5 Hz, 1H), 7.53
t, J = 7.8 Hz, 1H), 4.90 (d, J = 8.4 Hz, 1H), 4.14 (d, J = 2.4 Hz, 1H),
R
t (anti) = 33.94 min and 26.05 min
1
R
R
(
(
(
t
R
H NMR
1
=
8
2
3
3
.20–8.24 (m, 2H), 7.51–7.56 (m, 2H), 4.78–5.43 (m, 1H), 1.52–
.62 (m, 7H).
2
1
.58–2.67 (m, 1H), 2.32–2.54 (m, 2H), 2.09–2.16 (m, 1H), 1.82–
.86 (m, 1H), 1.36–1.71 (m, 4H).
4
one
.4.11. (S)-2-[(R)-Hydroxyl(2-nitrophenyl)methyl] cyclopentan-
5
c
4
ne
.4.5. (S)-2-[(R)-Hydroxy(4-cyanophenyl)methyl] cyclohexano-
5
c,8b
Enantiomeric excess was determined by HPLC with a Chiralpak
AS-H column (n-hexane/IPA, volume ratio 95:5), flow rate 1.0 mL/
22
D 3
White powder; mp 82–83 °C; [a] = +23.3 (c 1.55, CHCl ).
min, k = 225 nm; t
syn) = 22.75 and 36.83 min (major); H NMR (CDCl
R
(anti) = 28.22 min (major) and 31.09 min, t
R
(-
Enantiomeric excess was determined by HPLC with a Chiralpak
AD-H column (n-hexane/isopropanol, volume ratio 92:8), flow rate
1
3
, 300 MHz) d:
7
5
.78 ꢂ 7.81 (m, 2H), 7.59 ꢂ 7.72 (m, 1H), 7.38 ꢂ 7.57 (m, 1H),
.89 ꢂ 5.90 (d, J = 3 Hz, 1H), 5.41 ꢂ 5.44 (d, J = 8.4 Hz, 1H), 4.50
1
3
.0 mL/min, k = 267 nm;
1.98 min, t
(syn) = 23.20 min and 27.33 min (major); 1H NMR
): 7.65 (d, J = 8.1 Hz, 2H), 7.43 (d, J = 8.1 Hz, 2H),
.84 (d, J = 8.4 Hz, 1H), 4.07 (s, 1H), 2.47–2.62 (m, 2H), 2.31–2.41
m, 1H), 2.08–2.15 (m, 1H), 1.81–1.83 (m, 1H), 1.49–1.73 (m,
R
t (anti) = 40.88 min (major) and
R
(
(
2
1
br s, 1H), 2.65 ꢂ 2.85 (m, 1H), 2.26 ꢂ 2.60 (m, 2H), 1.95 ꢂ 2.26
(
300 MHz, CDCl
3
13
m, 2H), 1.69 ꢂ 1.8 (m, 2H); C NMR (CDCl
3
, 300 MHz): d 20.1,
0.4, 22.8, 26.5, 38.6, 54.7, 55.3, 66.4, 69.0, 123.9, 124.4, 127.9,
28.5, 128.6, 128.9, 133.1, 133.3, 138.6, 146.9, 219.1.
4
(
3
H), 1.32–1.41 (m, 1H).
0
2d,5d
4
ne
.4.6. (S)-2-[(R)-Hydroxy(4-fluorophenyl)methyl] cyclohexano-
4.4.12. 4-Hydroxyl-4-(4 -nitrophenyl)-butan-2-one
5
c,8b
[Daicel Chiralpak AS-H column, n-hexane/isopropanol = 70:30,
flow rate 1.0 mL/min, flow rate 1.0 mL/min, k = 254 nm; t (anti)
= 15.39 min and 12.08 min(major)]; H NMR (300 MHz, CDCl ) d:
2
2
[a]
D
= +27.5 (c 0.35, CHCl
3
). Enantiomeric excess was deter-
R
1
mined by HPLC with a Chiralpak AD-H column (n-hexane/iso-
3
propanol, volume ratio 90:10), flow rate 0.3 mL/min; k = 208 nm;
2.21 (s, 3H), 2.80–2.85 (m,2H), 3.56 (br s, 1H), 5.20–5.30 (m, 1H),
t
R
(anti) = 49.15 min and 44.19 min (major), t
R
(syn) = 29.38 min
7.52 (d, J = 7.0 Hz, 2H), 8.20 (d, J = 7.0 Hz, 2H).